Analytical Data
-
Gene name
GPR155
- Application
-
Alternative Names
PGR22
-
Species
Human
-
Source
Baculovirus
-
Tag
Strep;His;GFP
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z3F1
-
Expression Region
M1-T870
-
Protein Length
Full Length
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR155, a member of the G protein-coupled receptor (GPCR) family, has garnered attention in recent years due to its potential implications in neurological disorders and other pathophysiological conditions. It is predominantly expressed in the brain, particularly in regions associated with cognitive functions and motor control, suggesting a role in the modulation of neuronal signaling. Research indicates that GPR155 may participate in the regulation of the dopaminergic system, making it a candidate for studies related to neuropsychiatric diseases such as schizophrenia and depression. Furthermore, its unique structural features and expression patterns highlight its potential as a therapeutic target. Recent advancements in recombinant protein expression techniques have enabled the production of GPR155, facilitating detailed investigations into its receptor-ligand interactions, signaling pathways, and functional assays. Understanding the functional biology of GPR155 at the molecular level could provide insights into its role in health and disease, paving the way for novel therapeutic strategies that leverage its signaling mechanisms. As research progresses, GPR155 stands out as an intriguing target for drug discovery, particularly in the context of treating conditions linked to dysfunctional neurotransmission and neurodegeneration.
